Form 8-K - Current report:
SEC Accession No. 0001193125-24-246627
Filing Date
2024-10-29
Accepted
2024-10-29 17:01:05
Documents
40
Period of Report
2024-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889032d8k.htm   iXBRL 8-K 36544
2 EX-99.1 d889032dex991.htm EX-99.1 17148
3 EX-99.2 d889032dex992.htm EX-99.2 34434
7 GRAPHIC g889032ex99_2s10g1.jpg GRAPHIC 48772
8 GRAPHIC g889032ex99_2s11g1.jpg GRAPHIC 127359
9 GRAPHIC g889032ex99_2s12g1.jpg GRAPHIC 58879
10 GRAPHIC g889032ex99_2s13g1.jpg GRAPHIC 113295
11 GRAPHIC g889032ex99_2s14g1.jpg GRAPHIC 106737
12 GRAPHIC g889032ex99_2s15g1.jpg GRAPHIC 103894
13 GRAPHIC g889032ex99_2s16g1.jpg GRAPHIC 96000
14 GRAPHIC g889032ex99_2s17g1.jpg GRAPHIC 106881
15 GRAPHIC g889032ex99_2s18g1.jpg GRAPHIC 108847
16 GRAPHIC g889032ex99_2s19g1.jpg GRAPHIC 80213
17 GRAPHIC g889032ex99_2s1g1.jpg GRAPHIC 77407
18 GRAPHIC g889032ex99_2s20g1.jpg GRAPHIC 88756
19 GRAPHIC g889032ex99_2s21g1.jpg GRAPHIC 92747
20 GRAPHIC g889032ex99_2s22g1.jpg GRAPHIC 117159
21 GRAPHIC g889032ex99_2s23g1.jpg GRAPHIC 69323
22 GRAPHIC g889032ex99_2s24g1.jpg GRAPHIC 92620
23 GRAPHIC g889032ex99_2s25g1.jpg GRAPHIC 71745
24 GRAPHIC g889032ex99_2s2g1.jpg GRAPHIC 248904
25 GRAPHIC g889032ex99_2s3g1.jpg GRAPHIC 76279
26 GRAPHIC g889032ex99_2s4g1.jpg GRAPHIC 88404
27 GRAPHIC g889032ex99_2s5g1.jpg GRAPHIC 61507
28 GRAPHIC g889032ex99_2s6g1.jpg GRAPHIC 91469
29 GRAPHIC g889032ex99_2s7g1.jpg GRAPHIC 101524
30 GRAPHIC g889032ex99_2s8g1.jpg GRAPHIC 131985
31 GRAPHIC g889032ex99_2s9g1.jpg GRAPHIC 120517
  Complete submission text file 0001193125-24-246627.txt   3655536

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA spro-20241029.xsd EX-101.SCH 2870
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20241029_lab.xml EX-101.LAB 17996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20241029_pre.xml EX-101.PRE 11275
43 EXTRACTED XBRL INSTANCE DOCUMENT d889032d8k_htm.xml XML 3677
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 241406525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)